Join to View Full Profile
7830 Madison AveSte BIndianapolis, IN 46227
Phone+1 317-888-1100
Fax+1 317-888-1118
Are you Dr. Jain?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Anil Jain, MD is a nephrologist in Indianapolis, Indiana. He is currently licensed to practice medicine in Indiana, Illinois, and Kentucky.
Education & Training
University of Cincinnati Medical Center/College of MedicineResidency, Internal Medicine, 2003 - 2004
St Luke's HospitalResidency, Internal Medicine, 2002 - 2003
University of Cincinnati College of MedicineClass of 2003
SSM Health/Saint Louis University School of MedicineFellowship, Nephrology, 2000 - 2002
Mahatma Gandhi Institute of Medical ScienceClass of 1992
Certifications & Licensure
IN State Medical License 2007 - 2025
IL State Medical License 2007 - 2008
KY State Medical License 2007 - 2008
OH State Medical License 2003 - 2008
PA State Medical License 1983 - 1984
American Board of Internal Medicine Nephrology
Publications & Presentations
PubMed
- 37 citationsAsiatic acid induces endoplasmic reticulum stress and apoptotic death in glioblastoma multiforme cells both in vitro and in vivo.Chandagirikoppal V. Kavitha, Anil K. Jain, Chapla Agarwal, Angela Pierce, Amy K. Keating
Molecular Carcinogenesis. 2015-11-01 - 32 citationsSilibinin prevents prostate cancer cell-mediated differentiation of naïve fibroblasts into cancer-associated fibroblast phenotype by targeting TGF β2.Harold Ting, Gagan Deep, Anil K. Jain, Adela Cimic, Joseph Sirintrapun
Molecular Carcinogenesis. 2015-09-01 - 11 citationsBridging the gap: from biometrics to forensics.Anil K. Jain, Arun Ross
Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences. 2015-08-05
Press Mentions
New Algorithm to Enhance Diagnosis and Treatment of Drug-Resistant Bone, Joint, and Spine Tuberculosis: StudySeptember 13th, 2024
